Delving into the Latest Updates on Jincheng Haisi Pharmaceutical Co. Ltd. with Synapse

Overview

Basic Info

Introduction

Jincheng Haisi Pharmaceutical Co. Ltd. is a pharmaceutical manufacturing company that operates out of Jincheng, China. As a subsidiary of Jiangzhong Pharmaceutical Co., Ltd., the company has been in business since 1997 and is currently led by CEO Jian Wen Zhang.

Tags

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

Sodium channels	1

本试验旨在研究单次空腹口服晋城海斯制药有限公司研制、生产的雷贝拉唑钠肠溶片（20 mg）的药代动力学特征；以卫材（中国）药业有限公司生产的雷贝拉唑钠肠溶片（波利特®，20 mg）为参比制剂，比较两制剂中药动学参数Cmax、AUC0-t、AUC0-∞，评价两制剂的人体生物等效性。

[Translation]

The purpose of this study was to study the pharmacokinetic characteristics of a single fasting oral administration of rabeprazole sodium enteric-coated tablets (20 mg) developed and produced by Jincheng Haisi Pharmaceutical Co., Ltd.; using rabeprazole sodium enteric-coated tablets (Polite®, 20 mg) produced by Eisai (China) Pharmaceutical Co., Ltd. as the reference preparation, to compare the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations, and to evaluate the bioequivalence of the two preparations in humans.

Start Date03 Aug 2022

Sponsor / Collaborator

Jincheng Haisi Pharmaceutical Co. Ltd.

CTR20211562

/ CompletedNot Applicable

雷贝拉唑钠肠溶片人体生物等效性研究

[Translation] Study on the bioequivalence of rabeprazole sodium enteric-coated tablets in healthy volunteers

本试验旨在研究单次空腹和餐后口服晋城海斯制药有限公司研制、生产的雷贝拉唑钠肠溶片（20 mg）的药代动力学特征；以卫材（中国）药业有限公司生产的雷贝拉唑钠肠溶片（波利特®，20 mg）为参比制剂，比较两制剂中药动学参数Cmax、AUC0-t、AUC0-∞，评价两制剂的人体生物等效性。

[Translation]

The aim of this study was to investigate the pharmacokinetic characteristics of a single fasting and postprandial oral administration of rabeprazole sodium enteric-coated tablets (20 mg) developed and produced by Jincheng Haisi Pharmaceutical Co., Ltd.; using rabeprazole sodium enteric-coated tablets (Polite®, 20 mg) produced by Eisai (China) Pharmaceutical Co., Ltd. as the reference preparation, to compare the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations, and to evaluate the bioequivalence of the two preparations in humans.

Start Date20 Jul 2021

Sponsor / Collaborator

Jincheng Haisi Pharmaceutical Co. Ltd.

100 Clinical Results associated with Jincheng Haisi Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Jincheng Haisi Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Jincheng Haisi Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Jincheng Haisi Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data